d.HOLIDAY conference

Dimitris Moulavasilis

president & ceo,
Diaverum

Since he joined in October 2018, Dimitris has been at the helm of Diaverum’s ambitious vision of transforming the industry, by offering life-enhancing renal care and empowering patients to live fulfilling lives. He has been instrumental in guiding Diaverum on its digital journey to become a pioneer in integrated, AI-enabled, personalised dialysis care.
 
An established leader with over 30 years’ experience in the international healthcare services and medical technology sectors, Dimitris studied Biomedical Engineering at the Athens University of Applied Sciences. He also holds a Master of Business Administration from the University of Leicester.

Michaela Blomstrand

Director of Global Patient Experience AND Community Affairs,
Diaverum

Michaela heads up the global d.HOLIDAY programme at Diaverum. She is a certified dialysis nurse and holds a degree in Nursing. She has over ten years' experience of working with holiday dialysis.

Maria Chiara Durio, MBA

Managing Director,
Diaverum Italy

Maria Chiara is an experienced business leader, with a career centred in the pharmaceutical and healthcare industries, spanning from strategic marketing to business development and general management. She has led Diaverum Italy since May 2020.

Massimo Fontò

Country Nursing & Quality Manager and d.HOLIDAY Coordinator,
Diaverum Italy 

Massimo holds a bachelor’s degree in Nursing and is specialised in Forensic Nursing & Health Management. He has 10 years of dialysis experience and previously held the role of Integration Nurse in Diaverum Saudi Arabia.

Professor Loreto Gesualdo

Professor of Nephrology,
University of Bari, Italy

Prof. Gesualdo is a nephrologist and immunopathologist, with experience in the treatment of glomerular, tubular and renal vascular diseases. He studied at Case Western Reserve University, Cleveland and the University of Pittsburgh (USA). He is an expert in renal immunopathology and has worked in the fields of nephrology, dialysis and solid organ transplantation.

Currently, Prof. Gesualdo is the Director of the Nephrology, Dialysis and Transplantation Department of the DETO. He also coordinates a team of researchers at the Centre Rene and is responsible for one of the European nodes of the ErkNet network, as well as acting as the Coordinator of the Regional Transplantation Centre (Puglia region).

Professor Pesce

Type B University Researcher,
University of Bari, Italy

Professor Pesce obtained his PhD from Imperial College London, working in the sections of "Genetics and Genomics" at Royal Brompton Hospital and "MRC CSC Integrative Genomics and Medicine" at Hammersmith Hospital.

Dr Pesce deals with patients suffering from chronic kidney disease and glomerulonephritis and is also involved in the selection of patients for renal transplantation. He is an expert in Systems Medicine and e-Health, with a particular focus on the integration of multimodal data (e.g.: omics, histopathology, imaging and digital devices) that sees him collaborate with the Politecnico di Bari, where he is vice-coordinator of the degree course, "Medical Systems Engineering".

Antonio Tombas

Vice President, Spanish Dialysis Foundation
(Fundación Española Diálisis)

Antonio is the VP of the Spanish Dialysis Foundation, a position he has held since 2019. He was diagnosed with CKD in 1979, at just 17 years old. Since then, he has spent over five years undergoing haemodialysis treatment and has also had three kidney transplants. In 1984, he was the first CKD patient in Spain to take Ciclosporina (Sandimum).

Antonio’s experiences have led him to become a passionate advocate for CKD patients and have seen him become heavily involved in various Patient Associations. Outside of this, he is an entrepreneur with interests in technology and real estate, which have seen him travel all around the world. He is married with one son.

Dr Fernando Macário

Chief Medical Officer,
Diaverum

Dr Macário holds an M.D in nephrology and has broad experience in renal medicine and transplantation, including basic and clinical research. He was instrumental in shaping Diaverum’s policies to ensure the protection of patients and staff against COVID-19. This included being a vocal advocate for vaccination, leading to a 94% rate of clinical staff and 86% of patients being fully vaccinated (as of 11 April 2022), which is on the frontline of clinical standards.